Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-19 Purchase | 2025-12-23 07:25 am | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 56,000 | $1.81 | $101,360 | 2,532,934 (Indirect Direct) | View |
| 2025-11-18 Sale | 2025-11-19 4:34 pm | Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director | 168 | $1.87 | $314 | 7,500 (Indirect Direct) | View |
| 2025-06-10 Purchase | 2025-08-12 4:30 pm | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 129,000 | $1.596 | $205,884 | 303,000 (Direct) | View |
| 2023-10-19 Purchase | 2023-10-20 06:50 am | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 64,516 | $1.4025 | $90,484 | 132,516 (Direct) | View |
| 2023-01-03 Purchase | 2023-01-05 5:08 pm | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 110,000 | $1.4165 | $155,815 | 174,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Forster Eliot Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 22,500 | $0 | 22,540 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Elze Christian Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 22,500 | $0 | 325,500 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director | 22,500 | $0 | 22,668 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations | 75,000 | $0 | 282,929 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-04 5:00 pm | N/A 2035-09-03 | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 535,000 | $0 | 2,816,934 (Direct) | View |
Ownership | 2025-08-25 4:31 pm | N/A 2035-07-20 | Protalix BioTherapeutics Inc. | PLX | Mamlok Gilad Sr. VP and CFO | 0 | $0 | 597,990 (Direct) | View |
| 2024-09-23 Option Award(A) | 2024-11-05 5:00 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 90,909 | $0 | 660,909 (Indirect) | View |
| 2024-09-23 Option Award | 2024-09-24 5:00 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 99,010 | $0 | 669,010 (Indirect) | View |
| 2024-09-23 Option Award | 2024-09-24 5:00 pm | N/A 2034-09-23 | Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 5:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 263,960 | $0 | 2,281,934 (Indirect) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-14 Option Award | 2023-09-15 4:46 pm | N/A 2033-09-14 | Protalix BioTherapeutics Inc. | PLX | Forster Eliot Director | 85,715 | $0 | 85,715 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 800,000 | $0 | 1,953,458 (Indirect) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 201,903 | $0 | 570,000 (Indirect) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A 2033-08-15 | Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development | 35,115 | $0 | 70,230 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations | 187,344 | $0 | 207,929 (Indirect) | View |
| 2022-09-07 Option Award | 2022-09-09 5:04 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:04 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations | 340,000 | $0 | 340,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:03 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:03 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:02 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 750,000 | $0 | 750,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:02 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:01 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Bronfeld Zeev Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:01 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:01 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director | 50,000 | $0 | 50,000 (Direct) | View |